Myriad Genetics

                   

Scripps Discovery Might Be Early Step Toward Alzheimer's Drug: Scripps Discovery Might Be Early...

redorbit.com     13-Jul-2008          

By Patty Pensa, South Florida Sun-Sentinel Jul. 13--At the end of Esther Balogh's life, it was clear what Alzheimer's had stolen. She spent her days at an assisted living facility in Greenacres. Yet Balogh was certain she was...                    

comments

Health Winners & Losers: Insmed (at TheStreet.com)

yahoo.com     11-Jul-2008          

Health stocks managed to stay in the green Thursday amid -- and in some cases despite -- regulatory, business and clinical news. A Food and Drug Administration advisory panel determined that patients taking anti-seizure drugs...                    

comments

Bullish Catapult Breakout for Myriad Genetics Inc. (MYGN), article by TwinTrader.com

emailwire.com     08-Jul-2008   7 related          

DALLAS, Texas - TwinTrader.com announces the publication of Breakout for MYGN; highlighting public companies on the move and what’s behind the surge. Investors can view all of the Breakouts and other articles for free by...                    

comments

The Danish pharmaceutical company

pharmiweb.co.uk     07-Jul-2008          

Unexpected outcome of phase III study Av The Danish pharmaceutical company Lundbeck and the international pharmaceutical company Myriad Genetics have announced the results of a phase III study of Flurizan, for treatment of...                    

comments

                   

Neuro Sector Reviewed By NeuroInvestment

redorbit.com     07-Jul-2008   4 related          

NeuroInvestment today announced the release of its July/August issue, which overviews the CNS sector at midyear, and previews the second half of 2008. The major news at midyear was the Alzheimer's data which came from...                    

comments

                   
timesonline.co.uk: This undated artist's depiction shows the aeroshell of NASA's Phoenix Mars Lander spacecraft as it enters the Martian atmosphere timesonline.co.uk

Medical research is ‘hindered by out-of-date laws’

timesonline.co.uk     04-Jul-2008   4 related          

System is inefficient and corrupt, say scientists Russell Jenkins and Mark Henderson Research into new medicines is being impaired by intellectual property laws that are no longer suited to modern science, two Nobel laureates...                    

comments

MYRIAD GENETICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (EDGAR...

yahoo.com     02-Jul-2008   8 related          

| Request a Trial to NEW EDGAR Online Pro Form 8-K for MYRIAD GENETICS INC Other Events, Financial Statements and Exhibits Item 8.01. Other Events On June 30, 2008, Myriad Genetics, Inc. (the Company) announced results of its...                    

comments

                   

Analyst Actions: Fortune Brands, Netflix, Myriad Genetics

businessweek.com     01-Jul-2008   8 related          

Wachovia analyst Jonathan Feeney says, given Fortune Brands' new guidance, it looks like sales were slower than he thought, which was "clearly priced in." But he says he did not expect cost pressures from steel and particle...                    

comments

Health Winners & Losers: Halozyme (at TheStreet.com)

yahoo.com     01-Jul-2008   12 related          

Health stocks traded Tuesday on a variety of business and regulatory news. The Nasdaq and Amex biotechnology indices hopped 1.7% and 1.4%, respectively. They outdid the Amex pharmaceutical index, which registered a 0.8% rise,...                    

comments

                   
go.com: Alzheimers go.com

Myriad Genetics Stops Work on an Alzheimer's Drug

pharmiweb.co.uk     01-Jul-2008   51 related          

New York Times - Jul. 01, 2008 A drug under development by Myriad Genetics to treat Alzheimer's disease failed in a closely watched late-stage clinical trial, dealing another blow to efforts to combat the illness. Myriad said...                    

comments